ChemoMetec Raises Full-Year Outlook on Strong Demand, Lower Costs
The Danish company cited strong instrument demand and lower costs.
Related stories
CarMax targets mid-single-digit unit and mid-teens adjusted EPS CAGRs through FY2030
M impact | EARNINGS | Nov 03, 2026, 10:53 AM UTC
ADM Hamburg First-Half Net Profit Falls
ADM Hamburg reported lower first-half 2026 net profit and revenue.
L impact | EARNINGS | Nov 03, 2026, 10:48 AM UTC
Aramco Expects Gas Investments to Add Up to $15 Billion in Annual Cash Flow
Saudi Aramco expects its gas investments to generate $12 billion to $15 billion in additional annual operating cash flow by 2030, as it expands production and reduces domestic reli
M impact | EARNINGS | Nov 03, 2026, 10:46 AM UTC
Coca-Cola Europacific Partners Revenue Rises 6.5% in Third Quarter
Coca-Cola Europacific Partners reported a 6.5% revenue increase in the third quarter.
M impact | EARNINGS | Nov 03, 2026, 10:42 AM UTC
Power Grid Shares Fall 3.04% After FY27 Capitalisation Guidance Cut
Power Grid Corporation of India shares fell 3.04% to ₹259.55 on the NSE on Tuesday, down ₹8.15, after the company lowered its FY27 capitalisation guidance.
M impact | EARNINGS | Nov 03, 2026, 10:41 AM UTC
Lufthansa Turns More Cautious on Full-Year Outlook as Fuel Costs Rise
Lufthansa narrowed its full-year adjusted earnings guidance, citing higher fuel prices since the summer. Strong demand and cost discipline lifted third-quarter profit.
M impact | EARNINGS | Nov 03, 2026, 10:41 AM UTC